Cipla to sell entire stake of 51% in Saba Investment

16 May 2023 Evaluate

Cipla has entered into a binding term sheet to sell its entire stake of 51% held in Saba Investment, UAE (Saba) to Shibam Group Holding, UAE. Consequent to the sale, upon execution of the transaction, Saba and its subsidiaries viz Cipla Middle East Pharmaceuticals FZ LLC, UAE (CME) and Cipla Medica Pharmaceutical and Chemical Industries, Yemen (Cipla Medica), will cease to be subsidiaries of the Company. Consideration to be received from such sale/disposal is $6.50 million. The company will continue to service the market directly from Cipla, India, though with certain changes in the business model. 

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1405.00 5.65 (0.40%)
18-May-2024 09:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1536.40
Dr. Reddys Lab 5837.65
Cipla 1405.00
Zydus Lifesciences 1104.45
Lupin 1657.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.